ONO-2020-02: A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease (clinicaltrials.gov) - Oct 23, 2026 - P2 | N=260 | Completed | Sponsor: Ono Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Alzheimer's Disease • CNS Disorders
|